Galafold™ (migalastat) – New orphan drug approval
August 10, 2018 - The FDA announced the approval of Amicus Therapeutics’ Galafold (migalastat) for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.
Top